Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epclusa for Postpartum HCV in Women with OUD
NCT03057847Phase 4Completed
- Start
- Jan 2018
- Primary completion
- Feb 2022
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of velpatasvir in hepatitis C virus infection. Started Jan 2018; status: completed.
02
Drugs
velpatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT03057847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03057847.